Evaluation of Patient and Physician Satisfaction With the Zift eLevatIon of Facial Tissue Clinical Study

Exclusion Criteria

• •1. Known allergies to local anesthesia
• •2. Currently undergoing chemotherapy or radiation therapy for cancer
• •3. Known advanced osteoporosis that may lead to skull thinning
• •4. Taking long-term immunosuppressant therapy
• •5. Taking chronic anticoagulation therapy (including ASA and NSAIDS) which can't be stopped for 10 days before treatment.
• •6. Unable or unwilling to participate in follow-up examinations
• •7. Evidence of brow soft tissue thickness less than 4mm by physical exam, ultrasound or direct probe (probe at the time of procedure)
• •8. Stroke or TIE (Transient Ischemic Event) within the past 6 months and currently on anti-platelet or other blood thinners
• •9. Chronic facial paralysis due to trauma, Bells Palsy, or similar etiology
• •10. Treatment with neurotoxin in the past 6 months and during the study period. Subjects may undergo a neurotoxin washout for 6 months prior to study participation
• •11. Planned surgical procedures, fillers or other facial procedures during the study period.
• •12. Planned modification of the eyebrows (to include plucking or shaving) during the study period
• •13. Planned MRI during the study period
• •14. Known nickel allergy